510(k) device
Omnipod 5 SmartBolus Calculator
Insulet Corporation · Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX, Class II) · First FDA decision Jan 27, 2022, newest Jan 27, 2022Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "Omnipod 5 SmartBolus"
MAUDE reports
0
Brand "Omnipod 5 SmartBolus", since 2015
PubMed studies
0
Mentioning "Omnipod 5 SmartBolus"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Omnipod 5 SmartBolus CalculatorBreakthrough510(k)
K203772 · Decided Jan 27, 2022 · 400 days after receipt
Device type: Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38662CGS Administrators, LLCUpdated Sep 29, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38623Wellpoint FederalUpdated Jul 14, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38686WPS Insurance CorporationUpdated Jun 18, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38657Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38743Palmetto GBAUpdated Jul 19, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38664First Coast Service Options, Inc.Updated Jun 21, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38617Novitas Solutions, Inc.Updated Jun 21, 2024
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Omnipod 5 SmartBolus", any status and sponsor, newest update first.
No registered device study names "Omnipod 5 SmartBolus".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Omnipod 5 SmartBolus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QRX
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Omnipod 5 SmartBolus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QRX.
- SmartBolus CalculatorInsulet Corporation · 510(k) 2023
- MODI SystemDreaMed Diabetes, Ltd. · 510(k) 2026
- Dexcom Smart BasalDexcom, Inc. · 510(k) 2025
- BlueStar CGM insulin dose calculatorWelldoc, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.